11:57 EDT Cel Sci trading halted, news pending
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVM:
- CEL-SCI teams with Saudi Arabia pharmaceutical, healthcare company for Multikine
- Biotech Alert: Searches spiking for these stocks today
- CEL-SCI 2M share Spot Secondary priced at $2.50
- CEL-SCI announces common stock offering, no amount given
- CEL-SCI completes Breakthrough Medicine Designation application for Multikine